Biofrigas (BIOF) Q3 2026 earnings summary

Executive summary

• Q3 priorities: launch and deliver Habo Phase 2, support prospective customers with Klimatklivet applications, and turn the reference project into new sales opportunities.

• Commercial expansion is targeted for 2026, supported by technology verified in commercial operation and a growing market for small-scale LBG production.

Financial highlights

• Q3 net sales were KSEK 579 (19), related to Habo Phase 2; result after financial items was KSEK -1,463 (-2,527).

• 9M net sales were KSEK 579 (275); result after financial items was KSEK -7,392 (-8,427).

• Q3 operating result was KSEK -1,367 (-2,461); 9M operating result was KSEK -7,025 (-8,212).

• Q3 cash flow was KSEK -2,127 (-2,568); 9M cash flow was KSEK -712 (-6,136), with period-end cash of KSEK 1,466.

Outlook and guidance

• Habo Phase 2 commissioning is expected in Q1 2027; independent third-party inspection is planned for February 2027.

• September offers connected to prospective Klimatklivet applications totaled ~SEK 57M; these remain non-binding and are not confirmed orders.

• Priorities for the final quarter: advance Habo Phase 2, convert customer discussions into orders, and strengthen commercial positioning in the LBG market.